The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Korea's Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis
Abstract
In 2011, the rate of thyroid-cancer diagnoses in the Republic of Korea was 15 times that observed in 1993, yet thyroid-cancer mortality remains stable — a combination that suggests that the problem is overdiagnosis attributable to widespread thyroid-cancer screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Occult papillary carcinoma of the thyroid. A “normal” finding in finland. A systematic autopsy study
Harach, H. R., Franssila, K. O., & Wasenius, V.-M. (1985) · Cancer · doi:10.1002/1097-0142(19850801)56:3<531::aid-cncr2820560321>3.0.co;2-3 · Cited by 945
Cited by
The Global Burden of Cancer 2013
Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G., Woodbrook, R., Wolfe, C., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0735 · Cited by 2,707
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee
Tessler, F. N., Middleton, W. D., Grant, E. G., Hoang, J. K., Berland, L. L., Teefey, S. A., Cronan, J. J., Beland, M. D., Desser, T. S., Frates, M. C., et al. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.01.046 · Cited by 2,530
Nikiforov, Y. E., Seethala, R. R., Tallini, G., Baloch, Z. W., Basolo, F., Thompson, L. D. R., Barletta, J. A., Wenig, B. M., Al Ghuzlan, A., Kakudo, K., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0386 · Cited by 1,404
Evidence for overuse of medical services around the world
Brownlee, S., Chalkidou, K., Doust, J., Elshaug, A. G., Glasziou, P., Heath, I., Nagpal, S., Saini, V., Srivastava, D., Chalmers, K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32585-5 · Cited by 1,149
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
The changing incidence of thyroid cancer
Kitahara, C. M., & Sosa, J. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.110 · Cited by 1,051
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Pizzato, M., Li, M., Vignat, J., Laversanne, M., Singh, D., La Vecchia, C., & Vaccarella, S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00035-3 · Cited by 658
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
Miranda-Filho, A., Lortet-Tieulent, J., Bray, F., Cao, B., Franceschi, S., Vaccarella, S., & Dal Maso, L. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00027-9 · Cited by 601
Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K., & Haymart, M. R. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00020-x · Cited by 590
Evolving Understanding of the Epidemiology of Thyroid Cancer
Seib, C. D., & Sosa, J. A. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.10.002 · Cited by 495
Geographic influences in the global rise of thyroid cancer
Kim, J., Gosnell, J. E., & Roman, S. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0263-x · Cited by 473
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro-Green, A., & Kahaly, G. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0184-y · Cited by 398
Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules
Nikiforova, M. N., Mercurio, S., Wald, A. I., Barbi de Moura, M., Callenberg, K., Santana‐Santos, L., Gooding, W. E., Yip, L., Ferris, R. L., & Nikiforov, Y. E. (2018) · Cancer · doi:10.1002/cncr.31245 · Cited by 396
Sugitani, I., Ito, Y., Takeuchi, D., Nakayama, H., Masaki, C., Shindo, H., Teshima, M., Horiguchi, K., Yoshida, Y., Kanai, T., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0330 · Cited by 388
Overdiagnosis: what it is and what it isn’t
Brodersen, J., Schwartz, L. M., Heneghan, C., O’Sullivan, J. W., Aronson, J. K., & Woloshin, S. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2017-110886 · Cited by 371
Vaccarella, S., Dal Maso, L., Laversanne, M., Bray, F., Plummer, M., & Franceschi, S. (2015) · Thyroid · doi:10.1089/thy.2015.0116 · Cited by 363
Zhou, J., Yin, L., Wei, X., Zhang, S., Song, Y., Luo, B., Li, J., Qian, L., Cui, L., Chen, W., et al. (2020) · Endocrine · doi:10.1007/s12020-020-02441-y · Cited by 343
Oda, H., Miyauchi, A., Ito, Y., Yoshioka, K., Nakayama, A., Sasai, H., Masuoka, H., Yabuta, T., Fukushima, M., Higashiyama, T., et al. (2016) · Thyroid · doi:10.1089/thy.2015.0313 · Cited by 332
Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., Krist, A. H., et al. (2017) · JAMA · doi:10.1001/jama.2017.4011 · Cited by 313
Ha, E. J., Chung, S. R., Na, D. G., Ahn, H. S., Chung, J., Lee, J. Y., Park, J. S., Yoo, R.-E., Baek, J. H., Baek, S. M., et al. (2021) · Korean Journal of Radiology · doi:10.3348/kjr.2021.0713 · Cited by 298
Self-citationThe thyroid cancer epidemic, 2017 perspective
Roman, B. R., Morris, L. G., & Davies, L. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000359 · Cited by 297
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
Ito, Y., Miyauchi, A., & Oda, H. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.03.004 · Cited by 295
Zimmermann, M. B., & Galetti, V. (2015) · Thyroid Research · doi:10.1186/s13044-015-0020-8 · Cited by 279
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
Coles, A. J., Cohen, J. A., Fox, E. J., Giovannoni, G., Hartung, H.-P., Havrdova, E., Schippling, S., Selmaj, K. W., Traboulsee, A., Compston, D. A. S., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004354 · Cited by 277
Epidemiology of Thyroid Cancer
Kitahara, C. M., & Schneider, A. B. (2022) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-1440 · Cited by 259
South Korea’s Thyroid-Cancer “Epidemic” — Turning the Tide
Ahn, H. S., & Welch, H. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1507622 · Cited by 240
Self-citationKakudo, K., Higuchi, M., Hirokawa, M., Satoh, S., Jung, C. K., & Bychkov, A. (2017) · Cytopathology · doi:10.1111/cyt.12491 · Cited by 95
“8% (114/1180) of all malignant nodules in this cohort, a very small proportion, different from other patient series where nearly half of surgically-treated PTC was microcarcinoma.(8,15,75-77) However, PMC is not the only biologically indolent thyroid tumour and indeterminate thyroid nodules larger than 1 cm with benig…”
BackgroundArtificial intelligence defines protein-based classification of thyroid nodules
Sun, Y., Selvarajan, S., Zang, Z., Liu, W., Zhu, Y., Zhang, H., Chen, W., Chen, H., Li, L., Cai, X., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00442-x · Cited by 73
(2017) · New England Journal of Medicine · doi:10.1056/nejmc1709853 · Cited by 36
Shin, D. W., Suh, B., Lim, H., Yun, J. M., Song, S. O., & Park, Y. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3407 · Cited by 32
Chen, H., Luo, D., Zhang, L., Lin, X., Luo, Q., Yi, H., Wang, J., Yan, X., Li, B., Chen, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17398 · Cited by 29
The economics of diagnostic safety
Slawomirski, L., Kelly, D., de Bienassis, K., Kallas, K.-A., & Klazinga, N. (2025) · OECD Health Working Papers · doi:10.1787/fc61057a-en · Cited by 20
Practice of thyroid nodule management in the Gulf Cooperation Council countries
Jammah, A. A. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.1.25591 · Cited by 5
Metadata
- Authors
- Ahn, H. S., Kim, H. J., & Welch, H. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-11-06
- Volume
- 371
- Issue
- 19
- Pages
- 1765-1767
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2312782750
- Cited by
- 1,236
- References
- 1
- FWCI
- 68.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.